Literature DB >> 35242689

False-negative aldosterone-to-renin ratio in a primary aldosteronism patient complicated with primary polydipsia: case report.

Chengcheng Zheng1, Lianling Zhao1, Chang Zheng2, Yan Ren1, Haoming Tian1, Tao Chen1.   

Abstract

Aldosterone-to-renin ratio is the most reliable screening method of primary aldosteronism and has been widely used in clinical practice, but the index is influenced by many factors, some of which cause it false-negative, consequently leading to primary aldosteronism underdiagnosed. We report a rare case of a 27-year-old woman complaining of elevated arterial blood pressure and spontaneous hypokalemia but whose aldosterone-to-renin ratio were negative consecutively. She also had symptoms of polydipsia and polyuria for more than 20 years, with the volume of water intake and urine output up to 17 liters per day. Confirmatory tests of saline infusion test and captopril challenge test could not suppress plasma aldosterone concentration to the cutoff value. Abdominal contrast-enhanced CT suggested an adenoma on the right adrenal gland. After excluding other known causes of hypertension with hypokalemia, the patient was ultimately diagnosed with aldosterone-producing adenoma complicated with primary polydipsia. Complete clinical remission was achieved after unilateral adrenalectomy. The histopathology showed typical features of adrenocortical adenoma which was positive for CYP11B2 by immunohistochemistry, and next-generation sequencing results of tumor tissues revealed a missense mutation of the KCNJ5 gene [chr11:128781619, c.451 (exon 2) G>A]. All these findings supported the diagnosis of aldosterone-producing adenoma. This study has shown that negative aldosterone-to-renin ratio screening result cannot simply exclude primary aldosteronism. Comprehensive patient's evaluation should be taken to avoid missed diagnosis in clinical work, especially for those who have potentially curative surgery. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Primary aldosteronism; aldosterone-to-renin ratio; case report; primary polydipsia

Year:  2022        PMID: 35242689      PMCID: PMC8825511          DOI: 10.21037/gs-21-607

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  17 in total

1.  Inhibition of renin secretion in the isolated rat kidney by antidiuretic hormone.

Authors:  R Vandongen
Journal:  Clin Sci Mol Med       Date:  1975-07

Review 2.  Is there an unrecognized epidemic of primary aldosteronism? Pro.

Authors:  David A Calhoun
Journal:  Hypertension       Date:  2007-09       Impact factor: 10.190

3.  Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.

Authors:  W Oelkers; S Diederich; V Bähr
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

4.  Characteristics and outcomes of patients with profound hyponatraemia due to primary polydipsia.

Authors:  Clara O Sailer; Bettina Winzeler; Nicole Nigro; Isabelle Suter-Widmer; Birsen Arici; Martina Bally; Philipp Schuetz; Beat Mueller; Mirjam Christ-Crain
Journal:  Clin Endocrinol (Oxf)       Date:  2017-07-07       Impact factor: 3.478

5.  Dissociation of renin and aldosterone during dehydration: studies in a case of diabetes insipidus and adipsia.

Authors:  M A Schalekamp; S C Donker; A Jansen-Goemans; T D Fawzi; A Muller
Journal:  J Clin Endocrinol Metab       Date:  1976-08       Impact factor: 5.958

6.  The renin-aldosterone axis in patients with diabetes insipidus.

Authors:  A Antaraki; D Rangou; C Chlouverakis
Journal:  Clin Endocrinol (Oxf)       Date:  1994-04       Impact factor: 3.478

7.  High incidence of primary aldosteronism in 199 patients referred with hypertension.

Authors:  R D Gordon; M Stowasser; T J Tunny; S A Klemm; J C Rutherford
Journal:  Clin Exp Pharmacol Physiol       Date:  1994-04       Impact factor: 2.557

8.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

9.  Effects of vasopressin and its deamino-D-arginine analogue on renin release in the isolated perfused rat kidney.

Authors:  A Konrads; K G Hofbauer; U Werner; F Gross
Journal:  Pflugers Arch       Date:  1978-10-18       Impact factor: 3.657

10.  Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.

Authors:  Paolo Mulatero; Silvia Monticone; Jaap Deinum; Laurence Amar; Aleksander Prejbisz; Maria-Christina Zennaro; Felix Beuschlein; Gian Paolo Rossi; Tetsuo Nishikawa; Alberto Morganti; Teresa Maria Seccia; Yen-Hung Lin; Francesco Fallo; Jiri Widimsky
Journal:  J Hypertens       Date:  2020-10       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.